December 2019 FDA Recall Drug by Spectrum Laboratory Products
D-0628-2020 - Subpotent Drug

This Class II drug recall was voluntarily initiated by Spectrum Laboratory Products on December 11, 2019 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0628-2020

Reason for Recall
Subpotent Drug: Supplier indicated assay results did not meet specifications.
Initiated
12-11-2019
Reported
01-01-2020
Quantity
6.284 kg

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Spectrum Laboratory Products
Nationwide in the USA and Canada
Estriol [(16a, 17B)-Estra-1,3,5(10)-triene-3,16,17-triol; Oestriol] Micronized, USP, CAS 50-27-1, packaged in a) 1 G glass bottles, b) 5 G glass bottles, c) 25 G glass bottles, d) 100 G glass bottles, e) 500 G glass bottles, and f) 1 KG plastic bottles, Rx Only, Spectrum Chemical Mfg Corp., Gardena, CA 90248.

Batch or Lot Expiration Information

Lot# s: 1HG0308, 1HH0630, 1HI0854, 4HL0005,4HL0036, 4IH0032, Exp. 04/16/2021